81
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gene detection of VDR BsmI locus and its approteins, genes and growthplication in rational drug use in patients with osteoporosis

ORCID Icon, , , &
Pages 219-225 | Received 27 Nov 2023, Accepted 06 Jun 2024, Published online: 21 Jun 2024

References

  • Oumer KS, Liu Y, Yu Q, et al. Awareness of osteoporosis among 368 residents in China: a cross-sectional study. BMC Musculoskelet Disord. 2020;21:1–6. doi:10.1186/s12891-020-03217-1
  • Yiwu Q, Dezhi S, Shijie L, et al. Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways. Biomed Pharmacother. 2023;160:114347. doi:10.1016/j.biopha.2023.114347
  • Jones KDJ, Ulrich CH, Maureen K, et al. Vitamin D deficiency causes rickets in an urban informal settlement in Kenya and is associated with malnutrition. Matern Child Nutr. 2018;14(1):e12452. doi:10.1111/mcn.12452
  • Branch of Osteoporosis and Bone Mineral Diseases, Chinese Medical Association. Guidelines for the diagnosis and treatment of primary osteoporosis (2017). Chinese Journal of Osteoporosis and Bone Mineral Diseases. 2017;10(5):413–443.
  • Taha IM, Allah AMA, El Tarhouny S. Association of vitamin D gene polymorphisms and bone mineral density in healthy young Saudi females. Curr Mol Med. 2019;19(3):196–205. doi:10.2174/1566524019666190409122155
  • Chen B, Zhu W, Mu Y, et al. Association between vitamin D receptor BsmI, FokI, and Cdx2 polymorphisms and osteoporosis risk: an updated meta-analysis. Biosci Rep. 2020;40(7):BSR20201200. doi:10.1042/BSR20201200
  • Khan M, Bushara NZA, Kumar M, Mandal RK, Ahmad S, Khan S. Frequency of healthy control genotype of VDR gene polymorphisms in the Saudi population of the Ha'il region: a comparative study with worldwide population. J Environ Pathol Toxicol Oncol. 2024;43(1):61–69. doi:10.1615/JEnvironPatholToxicolOncol.2023048813
  • Geiger KE, Koeller DM, Harding CO, Huntington KL, Gillingham MB. Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food-based diets. Nutr Res. 2016;36(1):101–108. doi:10.1016/j.nutres.2015.11.007
  • Kowalówka M, Kosewski G, Lipiński D, Przysławski J. A comprehensive look at the -13910C>T LCT gene polymorphism as a molecular marker for vitamin D and calcium levels in young adults in Central and Eastern Europe: a preliminary study. Int J Mol Sci. 2023;24(12):10191. doi:10.3390/ijms241210191
  • Gao J, Wang L, Zhu J. Influence of BsmI polymorphism in vitamin D receptor gene on the risk of fracture in Caucasian populations: a meta analysis. Int J Clin Exp Med. 2015;8(1):589–597.
  • Yerezhepov D, Gabdulkayum A, Akhmetova A, et al. Pulmonary tuberculosis epidemiology and genetics in Kazakhstan. Front Public Health. 2024;12:1340673. doi:10.3389/fpubh.2024.1340673
  • Ramírez Ruiz C, Varo Cenarruzabeitia N, Martínez Villanueva M, Hernández Martínez AM, Noguera Velasco JA. Osteocalcin associates with bone mineral density and VDR gene polymorphisms in Type 1 and type 2 diabetes. Adv Lab Med. 2023;5(1):46–55.
  • Sadeghi M, Golshah A, Godiny M, et al. The most common vitamin D receptor polymorphisms (ApaI, FokI, TaqI, BsmI, and BglI) in children with dental caries: a systematic review and meta-analysis. Children. 2021;8(4):302. doi:10.3390/children8040302
  • Hamdi RA, Abdul-Qahar ZH, Ahmed SJ, et al. Assessment of Vitamin D receptor gene polymorphism in Iraqi women with polycystic ovary syndrome. J Clin Diagnostic Res. 2018;12(10):1–4.
  • Li L, Wan Q, Yang S, et al. Impact of vitamin D receptor gene polymorphism on chronic renal failure susceptibility. Ther Apher Dial. 2018;22(6): 575–587. doi:10.1111/1744-9987.12714
  • Xie X, Pan X, Zhang W, et al. A context hierarchical integrated network for medical image segmentation. Comp Elec Eng. 2022;101(6):108029. doi:10.1016/j.compeleceng.2022.108029
  • LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049–2102. doi:10.1007/s00198-021-05900-y
  • Wawrzyniak A, Skrzypczak-Zielińska M, Michalak M, et al. Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?. Front Endocrinol. 2023;13:1063762. doi:10.3389/fendo.2022.1063762
  • Mondockova V, Kovacova V, Zemanova N, et al. Vitamin D receptor gene polymorphisms affect osteoporosis-related traits and response to antiresorptive therapy. Genes (Basel). 2023;14(1):193. doi:10.3390/genes14010193
  • Górczyńska-Kosiorz S, Tabor E, Niemiec P, Pluskiewicz W, Gumprecht J. Associations between the VDR gene rs731236 (TaqI) polymorphism and bone mineral density in postmenopausal women from the RAC-OST-POL. Biomedicines. 2024;12(4):917. doi:10.3390/biomedicines12040917
  • Nardi A, Ventura L, Cozzi L, Tonini G. Clodronate news of efficacy in osteoporosis. Clin Cases Miner Bone Metab. 2016;13(1):33–35.
  • Del Real Á, Valero C, Olmos JM, et al. Pharmacogenetics of osteoporosis: a pathway analysis of the genetic influence on the effects of antiresorptive drugs. Pharmaceutics. 2022;14(4):776. doi:10.3390/pharmaceutics14040776
  • Stock JK. Update on SAMS: statin-associated muscle symptoms. Atherosclerosis. 2018;269:260–261. doi:10.1016/j.atherosclerosis.2017.12.032
  • Saito Y, Stamp LK, Caudle KE, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther. 2016;99(1):36–37. doi:10.1002/cpt.161